MM

MARGARET MANN

SAGE THERAPEUTICS · Cambridge, MA · registered since 2024
Registered · LDAActive

At a glance

Registered since
2024
Senate LDA system
Clients
1
last 3 years
Filings
4
5 agencies contacted
Activity
filings by quarter
Works on

Background

Career
Cambridge, MA
2024 - present

Specific issues

Mental Health Innovation at large substances - Cares Act. Telehealth and controlled substance prescribing habits for serious mental illness. Extension of Public Health Emergency Act for telehealth. Senate drug pricing reforms under Medicare Part D. TRIPS Waiver. Fixes to the Inflation Reduction Act of 2022 (P.L.117-169). Mental Health Care - PPD screening guidelines in Momnibus bills (H.R.3305/S.1606). PPD Screening.
Health Issues · 2024 Q4
Mental Health Innovation at large substances - Cares Act. Telehealth and controlled substance prescribing habits for serious mental illness. Extension of Public Health Emergency Act for telehealth. Senate drug pricing reforms under Medicare Part D. TRIPS Waiver. Fixes to the Inflation Reduction Act of 2022 (P.L.117-169). Mental Health Care - PPD screening guidelines in Momnibus bills (H.R.3305/S.1606).
Health Issues · 2024 Q3
Telehealth Medicare physician reimbursement. P.L.117-169 - Inflation Reduction Act of 2022 and potential fixes to the IRA. Maternal mental health legislation, like Momnibus (H.R.3305/S.1606).
Medicare/Medicaid · 2024 Q3

Clients

2024 · 4 filings
$██,███ / qtrUnlock

Filing history

2024 Q4
SAGE THERAPEUTICS
4Tlda.gov →
2024 Q3
SAGE THERAPEUTICS
Q3lda.gov →
2024 Q2
SAGE THERAPEUTICS
Q2lda.gov →
2024 Q1
SAGE THERAPEUTICS
Q1lda.gov →
Showing recent filings · full history on lda.gov